Search Results

Molecular farming expression of recombinant fusion proteins applied to skincare strategies.

• Authors : Yu G; College of Life and Environmental Sciences, Wenzhou University, Wen Zhou, China.; Zhao W

Subjects: Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/genetics ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/metabolism ; Molecular Farming*/Molecular Farming*/Molecular Farming*/methods

• Source: PeerJ [PeerJ] 2024 Sep 18; Vol. 12, pp. e17957. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).Publisher: PeerJ Inc Country of Publication: United States NLM ID: 101603425 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Architecting Multicompartmentalized, Giant Vesicles with Recombinant Fusion Proteins.

• Authors : Shin J; Department of Chemical Engineering, University of Florida, 1006 Center Drive, Gainesville, Florida 32611, United States.; Saha B

Subjects: Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/chemistry ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/genetics; Elastin/Elastin/Elastin/chemistry

• Source: Biomacromolecules [Biomacromolecules] 2024 Sep 09; Vol. 25 (9), pp. 6127-6134. Date of Electronic Publication: 2024 Aug 06.Publisher: American Chemical Society Country of Publication: United States NLM ID: 100892849 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Enzyme purification and sustained enzyme activity for pharmaceutical biocatalysis by fusion with phase-separating intrinsically disordered protein.

• Authors : Li X; Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.; Kuchinski LM

Subjects: Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/genetics ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/chemistry ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/isolation & purification

• Source: Biotechnology and bioengineering [Biotechnol Bioeng] 2024 Oct; Vol. 121 (10), pp. 3155-3168. Date of Electronic Publication: 2024 Jul 01.Publisher: Wiley Country of Publication: United States NLM ID: 7502021 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0290

Record details

Characterization of recombinant factor IX fusion proteins enabling subcutaneous administration.

• Authors : Schön K; Pharmacology & Toxicology, Research, CSL Innovation GmbH, Marburg, Hesse, Germany; Institute of Pharmacology, Biochemical-Pharmacological Center, University of Marburg, Marburg, Hesse, Germany.

Subjects: Factor IX*/Factor IX*/Factor IX*/pharmacokinetics ; Factor IX*/Factor IX*/Factor IX*/genetics ; Factor IX*/Factor IX*/Factor IX*/administration & dosage

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Oct; Vol. 22 (10), pp. 2713-2723. Date of Electronic Publication: 2024 Jul 15.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836

Record details

Dual-antigen fusion protein vaccination induces protective immunity against Candida albicans infection in mice.

• Authors : Jia K; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, China.; Zhang Y

Subjects: Fungal Vaccines*/Fungal Vaccines*/Fungal Vaccines*/immunology ; Fungal Vaccines*/Fungal Vaccines*/Fungal Vaccines*/administration & dosage ; Candida albicans*/Candida albicans*/Candida albicans*/immunology

• Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2406065. Date of Electronic Publication: 2024 Sep 26.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801.

• Authors : Nakatsumi H; Department of Gastroenterology, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.; Komatsu Y

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/mortality IFL protocol

• Source: International journal of cancer [Int J Cancer] 2024 Dec 15; Vol. 155 (12), pp. 2223-2231. Date of Electronic Publication: 2024 Aug 14.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of romiplostim on overall survival in chemotherapy induced thrombocytopenia. Blood. 2023;142(suppl 1):801-802.

Subjects: Thrombocytopenia*/Thrombocytopenia*/Thrombocytopenia*/chemically induced ; Thrombocytopenia*/Thrombocytopenia*/Thrombocytopenia*/diagnosis ; Thrombocytopenia*/Thrombocytopenia*/Thrombocytopenia*/drug therapy

• Source: Blood [Blood] 2024 Dec 12; Vol. 144 (24), pp. 2560.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

Successful Aflibercept Treatment for Choroidal Neovascularization in a Rare Case of Optic Disc Melanocytoma.

• Authors : Desmarest A; Department of Ophthalmology, Duchenne Hospital, Boulogne sur Mer, France.; Bouleau J

Subjects: Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/therapeutic use ; Choroidal Neovascularization*/Choroidal Neovascularization*/Choroidal Neovascularization*/drug therapy ; Choroidal Neovascularization*/Choroidal Neovascularization*/Choroidal Neovascularization*/etiology

• Source: The American journal of case reports [Am J Case Rep] 2024 Dec 09; Vol. 25, pp. e944211. Date of Electronic Publication: 2024 Dec 09.Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 101489566 Publication Model: Electronic Cited Medium:

Record details

Iron overload in acquired sideroblastic anemias and MDS: pathophysiology and role of chelation and luspatercept.

• Authors : Gattermann N; Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/metabolism ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/therapy ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/drug therapy

• Source: Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2024 Dec 06; Vol. 2024 (1), pp. 443-449.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 100890099 Publication Model: Print Cited Medium: Internet

Record details

Aflibercept high-dose (8mg) related intraocular inflammation (IOI) - a case series.

• Authors : Hoffmann L; Vista Augenklinik Binningen, Hauptstrasse 55, Binningen, 4102, Switzerland.; Michels S

Subjects: Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/administration & dosage ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/administration & dosage ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/adverse effects

• Source: BMC ophthalmology [BMC Ophthalmol] 2024 Dec 02; Vol. 24 (1), pp. 520. Date of Electronic Publication: 2024 Dec 02.Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415

Record details